Behçet syndrome: a contemporary view

H Yazici, E Seyahi, G Hatemi, Y Yazici - Nature Reviews Rheumatology, 2018 - nature.com
The presence of symptom clusters, regional differences in disease expression and
similarities with, for example, Crohn's disease suggest multiple pathological pathways are …

Behcet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions

E Alpsoy - The Journal of dermatology, 2016 - Wiley Online Library
Behçet's disease (BD) is a chronic, relapsing, inflammatory multisystem disease of unknown
etiology. Oral ulcers, genital ulcers, cutaneous lesions, and ocular and articular involvement …

2018 update of the EULAR recommendations for the management of Behçet's syndrome

G Hatemi, R Christensen, D Bang, B Bodaghi… - Annals of the …, 2018 - ard.bmj.com
Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet's syndrome (BS). The aim of the current effort was to update the …

Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials

S Stewart, KCK Yang, K Atkins, N Dalbeth… - Arthritis research & …, 2020 - Springer
Background Colchicine is a widely used drug to treat inflammatory diseases. Due to its long
historical use in medicine, controlled clinical trials have been small and there remains some …

Erythema nodosum: a practical approach and diagnostic algorithm

DM Pérez-Garza, S Chavez-Alvarez… - American journal of …, 2021 - Springer
Erythema nodosum is the most common form of panniculitis and is characterized by tender
erythematous nodules mainly in the lower limbs on the pretibial area. The exact cause of …

Colchicine: an ancient drug with novel applications

B Dasgeb, D Kornreich, K McGuinn… - British Journal of …, 2018 - academic.oup.com
Colchicine is a treatment for gout that has been used for more than a millennium. It is the
treatment of choice for familial Mediterranean fever and its associated complication …

Colchicine: old and new

A Slobodnick, B Shah, MH Pillinger… - The American journal of …, 2015 - Elsevier
Although colchicine has been a focus of research, debate, and controversy for thousands of
years, the US Food and Drug Administration just approved it in 2009. Over the past decade …

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

E Kural-Seyahi, I Fresko, N Seyahi, Y Ozyazgan, C Mat… - Medicine, 2003 - journals.lww.com
We surveyed the 20-year outcome of a cohort of patients with Behçet syndrome with
emphasis on both mortality and morbidity. During 1999 and 2000, we collected outcome …

EULAR recommendations for the management of Behçet disease

G Hatemi, A Silman, D Bang, B Bodaghi… - Annals of the …, 2008 - ard.bmj.com
Objectives: To develop evidence-based European League Against Rheumatism (EULAR)
recommendations for the management of Behçet disease (BD) supplemented where …

Current concepts in the etiology and treatment of Behçet disease

C Evereklioglu - Survey of ophthalmology, 2005 - Elsevier
Behçet disease is an idiopathic, multisystem, chronic, and recurrent disease characterized
by exacerbations alternating with phases of quiescence, episodic panuveitis, and …